Lifileucel: FDA-approved T-cell therapy for melanoma
Mei Li M. Kwong, James C. Yang
Abstract
This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.
Topics & Concepts
MelanomaMedicineMetastatic melanomaTumor-infiltrating lymphocytesCell therapyAdoptive cell transferOncologyDermatologyCancer researchImmunotherapyT cellCellInternal medicineImmunologyCancerBiologyImmune systemGeneticsCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers